CD274 and plasma cell myeloma: Before and after zoledronate stimulation, BM Vγ9Vδ2 T cells of MM patients expressed high levels of immune checkpoint receptor PD-1, surrounded by PD-L1+ myeloma cells and increased numbers of PD-L1+ MDSC.